The molecular mechanism of MAPK/ERK inactivation

Current Genomics

Volumn 5, Issue 4, 2004, Pages 385-393

  Yao, Zhong ^a   Seger, Rony ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

ERK; MAPK; MKP; Protein Ser Thr phosphatase; Protein Tyr phosphatase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; THREONINE; TYROSINE;

CELL STIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; MITOGENESIS; MOUSE; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 2342624538     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389202043349309     Document Type: Review

References (86)

1. Chen, Z.; Gibson, T.B.; Robinson, F.; Silvestro, L.; Pearson, G.; Xu, B.; Wright, A.; Vanderbilt, C.; Cobb, M.H.: MAP kinases. Chem. Rev., 2001, 101: 2449-2476.
2. Lewis, T.S.; Shapiro, P.S.; Ahn, N.G.: Signal transduction through MAP kinase cascades. Adv. Cancer. Res., 1998, 74: 49-139.
3. Seger, R.; Krebs, E.G.: The MAPK signaling cascade. FASEB. J., 1995, 9: 726-735.
4. Yung, Y.; Yao, Z.; Aebersold, D.M.; Hanoch, T.; Seger, R.: Altered regulation of ERK1b by MEK1 and PTP-SL.; and modified Elk1-phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs. J. Biol. Chem., 2001, 19: 19.
5. Yung, Y.; Yao, Z.; Hanoch, T.; Seger, R.: ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK. J. Biol. Chem., 2000, 275: 15799-15808.
6. Rubinfeld, H.; Hanoch, T.; Seger, R.: Identification of a cytoplasmic-retention sequence in ERK2. J. Biol. Chem., 1999, 274: 30349-30352.
7. Tanoue, T.; Adachi, M.; Moriguchi, T.; Nishida, E.: A conserved docking motif in MAP kinases common to substrates.; activators and regulators. Nat. Cell. Biol., 2000, 2: 110-116.
8. Adachi, M.; Fukuda, M.; Nishida, E.: Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO. J., 1999, 18: 5347-5358.
9. Brunet, A.; Roux, D.; Lenormand, P.; Dowd, S.; Keyse, S.; Pouyssegur, J.: Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO. J., 1999, 18: 664-674.
10. Khokhlatchev, A.V.; Canagarajah, B.; Wilsbacher, J.; Robinson, M.; Atkinson, M.; Goldsmith, E.; Cobb, M.H.: Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell, 1998, 93: 605-615.
11. Adachi, M.; Fukuda, M.; Nishida, E.: Nuclear Export of MAP Kinase (ERK) Involves a MAP Kinase Kinase (MEK)- dependent Active Transport Mechanism. J. Cell. Biol., 2000, 148: 849-856.
12. Zhang, F.; Strand, A.; Robbins, D.; Cobb, M.H.; Goldsmith, E.J.: Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature, 1994, 367: 704-711.
13. Canagarajah, B.J.; Khokhlatchev, A.; Cobb, M.H.; Goldsmith, E.J.: Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell, 1997, 90: 859-869.
14. Holland, P.M.; Cooper, J.A.: Protein modification: docking sites for kinases. Curr. Biol., 1999, 9: R329-331.
15. Sharrocks, A.D.; Yang, S.H.; Galanis, A.: Docking domains and substrate-specificity determination for MAP kinases. Trends. Biochem. Sci., 2000, 25: 448-453.
16. Chang, C.I.; Xu, B.E.; Akella, R.; Cobb, M.H.; Goldsmith, E.J.: Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell, 2002, 9: 1241-1249.
17. Eblen, S.T.; Catling, A.D.; Assanah, M.C.; Weber, M.J.: Biochemical and biological functions of the N-terminal.; noncatalytic domain of extracellular signal-regulated kinase 2. Mol. Cell. Biol., 2001, 21: 249-259.
18. Robinson, F.L.; Whitehurst, A.W.; Raman, M.; Cobb, M.H.: Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J. Biol. Chem., 2002, 277: 14844-14852.
19. Tanoue, T.; Maeda, R.; Adachi, M.; Nishida, E.: Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO. J., 2001, 20: 466-479.
20. Charles, C.H.; Abler, A.S.; Lau, L.F.: cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene. 1992, 7: 187-190.
21. Guan, K.L.; Broyles, S.S.; Dixon, J.E.: A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature, 1991, 350: 359-362.
22. Keyse, S.M.; Emslie, E.A.: Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature, 1992, 359: 644-647.
23. Zhao, Y.; Zhang, Z.Y.: The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3. J. Biol. Chem., 2001, 276: 32382-32391.
24. Slack, D.N.; Seternes, O.M.; Gabrielsen, M.; Keyse, S.M.: Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J. Biol. Chem., 2001, 276: 16491-16500.
25. Tanoue, T.; Yamamoto, T.; Nishida, E.: Modular structure of a docking surface on MAPK phosphatases. J. Biol. Chem., 2002, 277: 22942-22949.
26. Todd, J.L.; Tanner KG.; Denu JM: Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway. J. Biol. Chem., 1999, 274: 13271-13280.
27. Zhou, B.; Wang, Z.X.; Zhao, Y.; Brautigan, D.L.; Zhang, Z.Y.: The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J. Biol. Chem., 2002, 277: 31818-31825.
28. Ishibashi, T.; Bottaro, D.P.; Chan, A.; Miki, T.; Aaronson, S.A.: Expression cloning of a human dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 1992, 89: 12170-12174.
29. Shin, D.Y.; Ishibashi, T.; Choi, T.S.; Chung, E.; Chung, I.Y.; Aaronson, S.A.; Bottaro, D.P.: A novel human ERK phosphatase regulates H-ras and v-raf signal transduction. Oncogene, 1997, 14: 2633-2639.
30. Martell, K.J.; Seasholtz, A.F.; Kwak, S.P.; Clemens, K.K.; Dixon, J.E.: hVH-5: a protein tyrosine phosphatase abundant in brain that inactivates mitogen-activated protein kinase. J. Neurochem., 1995, 65: 1823-1833.
31. Tanoue, T.; Moriguchi, T.; Nishida, E.: Molecular cloning and characterization of a novel dual specificity phosphatase.; MKP-5. J. Biol. Chem., 1999, 274: 19949-19956.
32. Brondello, J.M.; Brunet, A.; Pouyssegur, J.; McKenzie, F.R.: The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem., 1997, 272: 1368-1376.
33. Grumont, R.J.; Rasko JE.; Strasser A.; Gerondakis S: Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene. Mol. Cell. Biol., 1996, 16: 2913-2921.
34. Brondello, J.M.; Pouyssegur, J.; McKenzie, F.R.: Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science, 1999, 286: 2514-2517.
35. Orlowski, R.Z.; Small, G.W.; Shi, Y.Y.: Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis. J. Biol. Chem., 2002, 277: 27864-27871.
36. Sugiura, R.; Kita, A.; Shimizu, Y.; Shuntoh, H.; Sio, S.O.; Kuno, T.: Feedback regulation of MAPK signalling by an RNA-binding protein. Nature, 2003, 424: 961-965.
37. Stewart, A.E.; Dowd, S.; Keyse, S.M.; McDonald, N.Q.: Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nat. Struct. Biol., 1999, 6: 174-181.
38. Zhou, B.; Zhang, Z.Y.: Mechanism of mitogen-activated protein kinase phosphatase-3 activation by ERK2. J. Biol. Chem., 1999, 274: 35526-35534.
39. Camps, M.; Chabert, C.; Muda, M.; Boschert, U.; Gillieron, C.; Arkinstall, S.: Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS. Lett., 1998, 425: 271-276.
40. Muda, M.; Theodosiou, A.; Gillieron, C.; Smith, A.; Chabert, C.; Camps, M.; Boschert, U.; Rodrigues, N.; Davies, K.; Ashworth, A.; et al. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. J. Biol. Chem., 1998, 273: 9323-9329.
41. Zhou, B.; Wu, L.; Shen, K.; Zhang, J.; Lawrence, D.S.; Zhang, Z.Y.: Multiple regions of MAP kinase phosphatase 3 are involved in its recognition and activation by ERK2. J. Biol. Chem., 2001, 276: 6506-6515.
42. Nichols, A.; Camps, M.; Gillieron, C.; Chabert, C.; Brunet, A.; Wilsbacher, J.; Cobb, M.; Pouyssegur, J.; Shaw, J.P.; Arkinstall, S.: Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3. J. Biol. Chem., 2000, 275: 24613-24621.
43. Zhang, J.; Zhou, B.; Zheng, C.F.; Zhang, Z.Y.: A Bipartite Mechanism for ERK2 Recognition by Its Cognate Regulators and Substrates. J. Biol. Chem., 2003, 278: 29901-29912.
44. Brunner, D.; Oellers, N.; Szabad, J.; Biggs, W.H. 3rd.; Zipursky, S.L.; Hafen, E.: A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways. Cell, 1994, 76: 875-888.
45. Farooq, A.; Chaturvedi, G.; Mujtaba, S.; Plotnikova, O.; Zeng, L.; Dhalluin, C.; Ashton, R.; Zhou, M.M.: Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2. Mol. Cell., 2001, 7: 387-399.
46. Fjeld, C.C.; Rice, A.E.; Kim, Y.; Gee, K.R.; Denu, J.M.: Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase. J. Biol. Chem., 2000, 275: 6749-6757.
47. Camps, M.; Nichols, A.; Gillieron, C.; Antonsson, B.; Muda, M.; Chabert, C.; Boschert, U.; Arkinstall, S.: Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science, 1998, 280: 1262-1265.
48. Dowd, S.; Sneddon, A.A.; Keyse, S.M.: Isolation of the human genes encoding the pyst1 and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J. Cell. Sci., 1998, 111: 3389-3399.
49. Chen, P.; Hutter, D.; Yang, X.; Gorospe, M.; Davis, R.J.; Liu, Y.: Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically. J. Biol. Chem., 2001, 276: 29440-29449.
50. Karim, F.D.; Rubin, G.M.: PTP-ER, a novel tyrosine phosphatase.; functions downstream of Ras1 to downregulate MAP kinase during Drosophila eye development. Mol. Cell., 1999, 3: 741-750.
51. Augustine, K.A.; Silbiger, S.M.; Bucay, N.; Ulias, L.; Boynton, A.; Trebasky, L.D.; Medlock, E.S.: Protein tyrosine phosphatase (PC12.; Br7.;S1) family: expression characterization in the adult human and mouse. Anat. Rec., 2000, 258: 221-234.
52. Boulanger, L.M.; Lombroso, P.J.; Raghunathan, A.; During, M.J.; Wahle, P.; Naegele, J.R.: Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci., 1995, 15: 1532-1544.
53. Adachi, M.; Sekiya, M.; Isobe, M.; Kumura, Y.; Ogita, Z.; Hinoda, Y.; Imai, K.; Yachi, A.: Molecular cloning and chromosomal mapping of a human protein-tyrosine phosphatase LC-PTP. Biochem. Biophys. Res. Commun., 1992, 186: 1607-1615.
54. Zanke, B.; Suzuki, H.; Kishihara, K.; Mizzen, L.; Minden, M.; Pawson, A.; Mak, T.W.: Cloning and expression of an inducible lymphoid-specific.; protein tyrosine phosphatase (HePTPase). Eur. J. Immunol., 1992, 22: 235-239.
55. Toledano-Katchalski, H.; Kraut, J.; Sines, T.; Granot-Attas, S.; Shohat, G.; Gil-Henn, H.; Yung, Y.; Elson, A.: Protein Tyrosine Phosphatase varepsilon Inhibits Signaling by Mitogen-Activated Protein Kinases. Mol. Cancer. Res., 2003, 1: 541-550.
56. Szedlacsek, S.E.; Aricescu. A.R.; Fulga, T.A.; Renault, L.; Scheidig, A.J.: Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation. J. Mol. Biol., 2001, 311: 557-568.
57. Pettiford, S.M.; Herbst, R.: The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP. Oncogene, 2000, 19: 858-869.
58. Pulido, R.; Zuniga, A.; Ullrich, A.: PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO., J., 1998, 17: 7337-7350.
59. Saxena, M.; Williams, S.; Brockdorff, J.; Gilman, J.; Mustelin, T.: Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem., 1999, 274: 11693-11700.
60. Munoz, J.J.; Tarrega, C.; Blanco-Aparicio, C.; Pulido, R.: Differential interaction of the tyrosine phosphatases PTP-SL.; STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. Biochem. J., 2003, 372: 193-201.
61. Tarrega, C.; Blanco-Aparicio, C.; Munoz, J.J.; Pulido, R.: Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP. J. Biol. Chem., 2002, 277: 2629-2636.
62. Zuniga, A.; Torres, J.; Ubeda, J.; Pulido, R.: Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J. Biol. Chem., 1999, 274: 21900-21907.
63. Blanco-Aparicio, C.; Torres, J.; Pulido, R.: A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J. Cell. Biol., 1999, 147: 1129-1136.
64. Saxena, M.; Williams, S.; Tasken, K.; Mustelin, T.: Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat. Cell. Biol., 1999, 1: 305-311.
65. Paul, S.; Nairn, A.C.; Wang, P.; Lombroso, P.J.: NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci., 2003, 6: 34-42.
66. Cayla, X.; Goris, J.; Hermann, J.; Hendrix, P.; Ozon, R.; Merlevede, W.: Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. Biochemistry, 1990, 29: 658-667.
67. Wassarman, D.A.; Solomon, N.M.; Chang, H.C.; Karim, F.D.; Therrien, M.; Rubin, G.M.: Protein phosphatase 2A positively and negatively regulates Ras1-mediated photoreceptor development in Drosophila. Genes. Dev., 1996, 10: 272-278.
68. Mateer, S.C.; Fedorov, S.A.; Mumby, M.C.: Identification of structural elements involved in the interaction of simian virus 40 small tumor antigen with protein phosphatase 2A. J. Biol. Chem., 1998, 273: 35339-35346.
69. Sontag, E.; Fedorov, S.; Kamibayashi, C.; Robbins, D.; Cobb, M.; Mumby, M.: The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell, 1993, 75: 887-897.
70. Alessi, D.R.; Gomez, N.; Moorhead, G.; Lewis, T.; Keyse, S.M.; Cohen, P.: Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase.; but not CL100.; in various cell lines. Curr. Biol., 1995, 5: 283-295.
71. Heriche, J.K.; Lebrin, F.; Rabilloud, T.; Leroy, D.; Chambaz, E.M.; Goldberg, Y.: Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science, 1997, 276: 952-955.
72. Silverstein, A.M.; Barrow, C.A.; Davis, A.J.; Mumby, M.C.: Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. Proc. Natl. Acad. Sci. USA, 2002, 99: 4221-4226.
73. Li, S.P.; Junttila, M.R.; Han, J.; Kahari, V.M.; Westermarck, J.: p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2. Cancer. Res., 2003, 63: 3473-3477.
74. Westermarck, J.; Li, S.P.; Kallunki, T.; Han, J.; Kahari, V.M.: p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol. Cell. Biol., 2001, 21: 2373-2383.
75. Avdi, N.J.; Malcolm, K.C.; Nick, J.A.; Worthen, G.S.: A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J. Biol. Chem., 2002, 277: 40687-40696.
76. Mitsuhashi, S.; Shima, H.; Tanuma, N.; Matsuura, N.; Takekawa, M.; Urano, T.; Kataoka, T.; Ubukata, M.; Kikuchi, K.: Usage of tautomycetin.; a novel inhibitor of protein phosphatase 1 (PP1).; reveals that PP1 is a positive regulator of Raf-1 in. vivo. J. Biol. Chem., 2003, 278: 82-88.
77. Tian, J.; Karin, M: Stimulation of Elk1 transcriptional activity by mitogen-activated protein kinases is negatively regulated by protein phosphatase 2B (calcineurin). J. Biol. Chem., 1999, 274: 15173-15180.
78. Tamura, S.; Hanada, M.; Ohnishi, M.; Katsura, K.; Sasaki, M.; Kobayashi, T.: Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur. J. Biochem., 2002, 269: 1060-1066.
79. Yao, Z.; Dolginov, Y.; Hanoch, T.; Yung, Y.; Ridner, G.; Lando, Z.; Zharhary, D.; Seger, R.: Detection of partially phosphorylated forms of ERK by monoclonal antibodies reveals spatial regulation of ERK activity by phosphatases [In Process Citation]. FEBS. Lett., 2000, 468: 37-42.
80. Wang, P.Y.; Liu, P.; Weng, J.; Sontag, E.; Anderson, R.G.: A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity. EMBO. J., 2003, 22: 2658-2667.
81. Kassel, O.; Sancono, A.; Kratzschmar, J.; Kreft, B.; Stassen, M.; Cato, A.C.: Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO. J., 2001, 20: 7108-7116.
82. Muda, M.; Boschert, U.; Dickinson, R.; Martinou, J.C.; Martinou, I.; Camps, M.; Schlegel, W.; Arkinstall, S.: MKP-3.; a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem., 1996, 271: 4319-4326.
83. Li, M.; Zhou, J.Y.; Ge, Y.; Matherly, L.H.; Wu, G.S.: The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J. Biol. Chem., 2003, 29: 29.
84. Yin, Y.; Liu, Y.X.; Jin, Y.J.; Hall, E.J.; Barrett, J.C.: PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature, 2003, 422: 527-531.
85. Camps, M.; Nichols, A.; Arkinstall, S.: Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB. J., 2000, 14: 6-16.
86. Keyse, S.M.: Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell. Biol., 2000, 12: 186-192.